INTERNATIONAL PATENT: NAVITOR PHARMACEUTICALS, INC. FILES APPLICATION FOR "MEFLULEUCIN FOR USE IN THE TREATMENT OF SUICIDAL IDEATIONS ASSOCIATED WITH DEPRESSION"

GENEVA, April 29 -- NAVITOR PHARMACEUTICALS, INC. (16 Liberty SquarePMB #284Boston, Massachusetts 02109) filed a patent application (PCT/US2025/051261) for "MEFLULEUCIN FOR USE IN THE TREATMENT OF SUICIDAL IDEATIONS ASSOCIATED WITH DEPRESSION" on Oct 16, 2025. With publication no. WO/2026/085331, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CERESOLI-BORRONI, Gianpiera (c/o Supernus Pharmaceuticals, Inc.9715 Key West AvenueRockville, Maryland 20850), PATEL, Yashvanti (c/o Supernus Pharmaceuticals, Inc.9715 Key West Aven...